RARS1 and obesity disorder: For example, pharmacological RA has been reported to inhibit adipogenesis by activating Wnt signaling [33] and PPARγ [34], or promoting the browning of WAT by inducing beige adipose progenitors [35] via RA receptors (RARs), providing a beneficial effect in obesity prevention.